Article

Pharmacies Sell Scarce Drugs to Secondary Distributors: Report

Secondary drug distributors acquired about 70% of drugs in short supply from pharmacies, according to a Congressional report that tracked the pedigrees of 300 drugs (PDF) bought and sold on the gray market.

The report, released today during a Senate Committee on Commerce, Science and Transportation hearing, is part of the investigation into gray market activity that Rep. Elijah Cummings (D-Md.) launched last year.

Read the full story: http://tinyurl.com/c3uqfwb

Source: ModernHealthcare.com

Related Videos
Bridgette J. Picou, LVN, ACLPN, The Well Project
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Steven Daniel Daveluy, MD, FAAD
Shawn Kwatra, MD, FAAD
Dr Xin Hu
Elizabeth Jones, MD, FAAD.
Related Content
Long COVID | Image credit: Parradee – stock.adobe.com
March 11th 2025

Studies Highlight Lingering Risks and Disparities of Long COVID

Hayden E. Klein
Long-term effects of COVID-19 include lingering symptoms that take months to improve, more severe illness for cancer survivors, and a higher risk of death after infection for people living in rural areas.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Newer technology may play an important role in aiding early skin cancer diagnosis, new research suggests. | Image credit: InsideCreativeHouse - stock.adobe.com
March 11th 2025

AI, Other Technologies May Help Narrow Gender Disparities in Melanoma

Jared Kaltwasser
Men with melanoma tend to be diagnosed later and have worse outcomes. Artificial intelligence can help change that, a review suggests.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
inflammatory bowel disease | Image credit: Aliaksandr Marko - stock.adobe.com
March 11th 2025

Addressing Disparities in IBD Care to Reduce Costs and Improve Access

Skylar Jeremias
Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments, increasing biosimilar adoption, and implementing policies that reduce financial disparities and improve long-term patient outcomes.
Aging | Image credit: smolaw11 - stock.adobe.com
March 11th 2025

Biological Aging Linked to Colorectal Cancer Risk Regardless of Gender

Pearl Steinzor
Biological age, rather than chronological age, may be a stronger predictor of colorectal cancer risk—especially in older adults.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo